// App-Quantinova.ai

101 : Efficacy of tocilizumab use in giant cell arteritis (GCA) and Takayasu arteritis (TA) patients allowing glucocorticoid dose reduction

Researchers

Presenter

  • Malinder Singh

Principal Investigators

  • Naomi Scott

  • Barbara Hauser

Medical Centers

  • Clinical Rheumatology, Western General Hospital, Edinburgh, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Large vessel vasculitis

  • Giant cell arteritis

  • Takayasu arteritis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved